Miami, FL – August 7, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Glucose Health, Inc. (OTC Pink: GLUC).
Diabetes is increasing at an alarming rate in the United States. According to the CDC’s (Centers for Disease Control) National Diabetes Statistics Report for 2020 cases of diabetes have risen to an estimated 34.2 million
A year ago, Investor’s Business Daily pointed out the fact that medical device companies are unleashing new diabetes treatment products that promote improved quality of life for patients.
Abbott Labs (NYSE: ABT), Medtronic (NYSE: MDT) and Tandem Diabetes (NASADQ: TNDM) are frontrunners in the medical device space.
But, there could be a smarter and more profitable investment; diabetic nutrition. In fact, Abbot Labs is the leader in the diabetic nutrition category with its Glucerna brand sold at pharmacies, and clinics nationwide.
Have a look at Glucose Health, Inc. (OTC Pink: GLUC). Glucose Health manufacturers nutritional beverages for the diabetic-adult nutrition consumer retail category under the registered trademark GLUCODOWN®. GLUCODOWN® is infused with a special form of diabetic fiber demonstrated in more than 20 clinical studies to help maintain healthy blood sugar levels and regular digestive health.
Glucose Health, Inc. (OTC Pink: GLUC) just announced triple-digit sales increases at Amazon (NASDAQ: AMZN) as its diabetic customers increasingly buy GLUCODOWN® during COVID-19. GLUCODOWN® is also sold nationwide in-store at Walmart pharmacies (NYSE: WMT), now the third largest pharmacy retailer after Walgreens and CVS.
What are the sales of this company going to look like when the latest GLUCODOWN® sales numbers from Amazon and Walmart come on the books during Q2 and Q3? Over the past 12 months, GLUC has seen a range of approximately $.20 – $1.90 per share and with only 12.5 million shares outstanding, GLUC could be the best value in the diabetes space and should be on everybody’s watch list.
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.